933
Views
18
CrossRef citations to date
0
Altmetric
Review Articles

Tick-borne encephalitis virus: molecular determinants of neuropathogenesis of an emerging pathogen

, , , , , , , , & show all
Pages 472-493 | Received 06 Dec 2018, Accepted 03 Jun 2019, Published online: 03 Jul 2019

References

  • Aberle JH, Schwaiger J, Aberle SW, Stiasny K, Scheinost O, Kundi M, Chmelik V, Heinz FX. 2015. Human CD4+ T helper cell responses after tick-borne encephalitis vaccination and infection. PLoS One. 10:e0140545.
  • Albinsson B, Vene S, Rombo L, Blomberg J, Lundkvist Å, Rönnberg B. 2018. Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017. Euro Surveill. 23(3):pii=17-00838.
  • Allison SL, Stadler K, Mandl CW, Kunz C, Heinz FX. 1995a. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol. 69:5816–5820.
  • Amato-Gauci A, Zeller H. 2012. Tick-borne encephalitis joins the diseases under surveillance in the European Union. Euro Surveill. 17:pii: 20299.
  • Andzhaparidze OG, Rozina EE, Bogomolova NN, Boriskin YS. 1978. Morphological characteristics of the infection of animals with tick-borne encephalitis virus persisting for a long time in cell cultures. Acta Virol. 22:218–224.
  • Ashgar N, Lee YP, Nilsson E, Lindqvist R, Melik W, Kröger A, Överby AK, Johansson M. 2016. The role of the poly(A) tract in the replication and virulence of tick-borne encephalitis virus. Sci Rep. 6:39265.
  • Aubry F, Nougairède A, de Fabritus L, Piorkowski G, Gould EA, de Lamballerie X. 2015. “ISA-Lation” of single-stranded positive-sense RNA viruses from non-infectious clinical/animal samples. PLoS One. 10:e0138703.
  • Aubry F, Nougairède A, de Fabritus L, Querat G, Gould EA, de Lamballerie X. 2014. Single-stranded positive-sense RNA viruses generated in days using infectious subgenomic amplicons. J Gen Virol. 95:2462–2467.
  • Aubry F, Nougairède A, Gould EA, de Lamballerie X. 2015. Flavivirus reverse genetic systems, construction techniques and applications: a historical perspective. Antiviral Res. 114:67–85.
  • Barkhash AV, Babenko VN, Voevoda MI, Romaschenko AG. 2016. Association of IL28B and IL10 gene polymorphism with predisposition to tick-borne encephalitis in a Russian population. Ticks Tick Borne Dis. 7:808–812.
  • Barkhash AV, Perelygin AA, Babenko VN, Brinton MA, Voevoda MI. 2012. Single nucleotide polymorphism in the promoter region of the CD209 gene is associated with human predisposition to severe forms of tick-borne encephalitis. Antiviral Res. 93:64–68.
  • Barkhash AV, Voevoda MI, Romaschenko AG. 2013. Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population. Antiviral Res. 99:136–138.
  • Barkhash AV, Yurchenko AA, Yudin NS, Ignatieva EV, Kozlova IV, Borishchuk IA, Pozdnyakova LL, Voevoda MI, Romaschenko AG. 2018. A matrix metalloproteinase 9 (MMP9) gene single nucleotide polymorphism is associated with predisposition to tick-borne encephalitis virus-induced severe central nervous system disease. Ticks Tick Borne Dis. 9:763–767.
  • Belikov SI, Kondratov IG, Potapova UV, Leonova GN. 2014. The relationship between the structure of the tick-borne encephalitis virus strains and their pathogenic properties. PLoS One. 9:e94946.
  • Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, Park GS, Boer E, Wolfinbarger JB, Bloom ME. 2005. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol. 79:12828–12839.
  • Bhardwaj S, Holbrook M, Shope RE, Barrett AD, Watowich SJ. 2001. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol. 75:4002–4007.
  • Bílý T, Palus M, Eyer L, Elsterová J, Vancová M, Růžek D. 2015. Electron tomography analysis of tick-borne encephalitis virus infection in human neurons. Sci Rep. 5:10745
  • Blom K, Braun M, Pakalniene J, Dailidyte L, Béziat V, Lampen MH, Klingström J, Lagerqvist N, Kjerstadius T, Michaëlsson J, et al. 2015. Specificity and dynamics of effector and memory CD8 T cell responses in human tick-borne encephalitis virus infection. PLoS Pathog. 11:e1004622
  • Blom K, Braun M, Pakalniene J, Lunemann S, Enqvist M, Dailidyte L, Schaffer M, Lindquist L, Mickiene A, Michaëlsson J, et al. 2016. NK cell responses to human tick-borne encephalitis virus infection. J Immunol. 197:2762–2771.
  • Blom K, Cuapio A, Sandberg JT, Varnaite R, Michaëlsson J, Björkström NK, Sandberg JK, Klingström J, Lindquist L, Gredmark Russ S, Ljunggren HG. 2018. Cell-mediated immune responses and immunopathogenesis of human tick-borne encephalitis virus-infection. Front Immunol. 9:2174
  • Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, Heinz FX, Rey FA. 2004. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 23:728–738.
  • Brinton MA, Perelygin AA. 2003. Genetic resistance to flaviviruses. Adv Virus Res. 60:43–85.
  • Bugrysheva JV, Matveeva VA, Dobrikova EY, Bykovskaya NV, Korobova SA, Bakhvalova VN, Morozova OV. 2001. Tick-borne encephalitis virus NS1 glycoprotein during acute and persistent infection of cells. Virus Res. 76:161–169.
  • Chambers TJ, Hahn CS, Galler R, Rice CM. 1990. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 44:649–688.
  • Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, Fletterick RJ, Rice CM. 1990. Evidence that the N-terminal domain of non-structural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci USA. 87:8898–8902.
  • Dai X, Shang G, Lu S, Yang J, Xu J. 2018. A new subtype of Eastern tick-borne encephalitis virus discovered in Qinghai-Tibet Plateau, China. Emerg Microb Infect. 7:74.
  • De Fabritus L, Nougairède A, Aubry F, Gould EA, de Lamballerie X. 2015. Attenuation of tick-borne encephalitis virus using large-scale random codon reencoding. PLoS Pathog. 11:e1004738.
  • De Fabritus L, Nougairède A, Aubry F, Gould EA, de Lamballerie X. 2016. Utilisation of ISA reverse genetics and large-scale random codon re-encoding to produce attenuated strains of tick-borne encephalitis virus within days. PLoS One. 11:e0159564.
  • de Graaf JA, Reimerink JH, Voorn GP, Bij de Vaate EA, de Vries A, Rockx B, Schuitemaker A, Hira V. 2016. First human case of tick-borne encephalitis virus infection acquired in The Netherlands. Euro Surveill. 21:pii = 30318.
  • Dietmann A, Putzer D, Beer R, Helbok R, Pfausler B, Nordin AJ, Virgolini I, Grams AE, Schmutzhard E. 2016. Cerebral glucose hypometabolism in tick-borne encephalitis, a pilot study in 10 Patients. Int J Infect Dis. 51:73–77.
  • Ecker M, Allison SL, Meixner T, Heinz FX. 1999. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol. 80:179–185.
  • Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B. 2002. An RNA cap (nucleoside-29-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J. 21:2757–2768.
  • Elshuber S, Allison SL, Heinz FX, Mandl CW. 2003. Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J Gen Virol. 84:183–191.
  • Engel AR, Rumyantsev AA, Maximova OA, Speicher JM, Heiss B, Murphy BR, Pletnev AG. 2010. The neurovirulence and neuroinvasiveness of chimeric tickborne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3’ non-coding region of the genome. Virology 405:243–252.
  • Ershova AS, Gra OA, Lyaschuk AM, Grunina TM, Tkachuk AP, Bartov MS, Savina DM, Sergienko OV, Galushkina ZM, Gudov VP, et al. 2016. Recombinant domains III of tick-borne encephalitis virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice. BMC Infect Dis. 16:544.
  • Ferenczi E, Bán E, Abrahám A, Kaposi T, Petrányi G, Berencsi G, Vaheri A. 2008. Severe tick-borne encephalitis in a patient previously infected by West Nile virus. Scand J Infect Dis. 40:759–761.
  • Fialová A, Cimburek Z, Iezzi G, Kopecký J. 2010. Ixodes ricinus tick saliva modulates tick-borne encephalitis virus infection of dendritic cells. Microbes Infect. 12:580–585.
  • Fokina GI, Malenko GV, Levina LS, Koreshkova GV, Rzhakhova OE, Mamonenko LL, Pogodina VV, Frolova MP. 1982. Persistence of tick-borne encephalitis virus in monkeys. V. Virus localization after subcutaneous inoculation. Acta Virol. 5:369–375.
  • Formanová P, Černý J, Bolfíková BČ, Valdés JJ, Kozlova I, Dzhioev Y, Růžek D. 2015. Full genome sequences and molecular characterization of tick-borne encephalitis virus strains isolated from human patients. Ticks Tick Borne Dis. 6:38–46.
  • Frolova TV, Frolova MP, Pogodona VV, Sobolev SG, Karmysheva V. 1987. [Pathogenesis of persistent and chronic forms of tick-borne encephalitis (experimental study)]. Zh Nevropatol Psikhiatr Im S S Korsakova. 87:170–178.
  • Frolova MP, Pogodina VV. 1984. Persistence of tick-borne encephalitis virus in monkeys. VI. Pathomorphology of chronic infection in central nervous system. Acta Virol. 3:232–239.
  • Füzik T, Formanová P, Růžek D, Yoshii K, Niedrig M, Plevka P. 2018. Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody. Nat Commun. 9:436.
  • Gelpi E, Preusser M, Garzuly F, Holzmann H, Heinz FX, Budka H. 2005. Visualization of Central European tick-borne encephalitis infection in fatal human cases. J Neuropathol Exp Neurol. 64:506–512.
  • Gelpi E, Preusser M, Laggner U, Garzuly F, Holzmann H, Heinz FX, Budka H. 2006. Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue. J Neurovirol. 12:322–327.
  • Goto A, Hayasaka D, Yoshii K, Mizutani T, Kariwa H, Takashima I. 2003. A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness. Vaccine 21:4043–4351.
  • Goto A, Yoshii K, Obara M, Ueki T, Mizutani T, Kariwa H, Takashima I. 2005. Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion. Vaccine 23:3043–3052.
  • Gresíková M. 1958. Excretion of the tickborne encephalitis virus in the milk of subcutaneously infected cows. Acta Virol. 2:188–192.
  • Gresíková M, Weidnerová K, Nosek J, Rajcáni J. 1972. Experimental pathogenicity of tick-borne encephalitis virus for dogs. Acta Virol. 16:336–340.
  • Gresikova-Kohutova M, Albrecht P. 1959. Experimental pathogenicity of the tick-borne encephalitis virus for the green lizard, Lacerta viridis (laurenti 1768). J Hyg Epidemiol Microbiol Immunol. 3:258–263.
  • Gritsun TS, Desai A, Gould EA. 2001. The degree of attenuation of tick-borne encephalitis virus depends on the cumulative effects of point mutations. J Gen Virol. 82:1667–1675.
  • Gritsun TS, Frolova TV, Zhankov AI, Armesto M, Turner SL, Frolova MP, Pogodina VV, Lashkevich VA, Gould EA. 2003. Characterization of a Siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J Virol. 77:25–36.
  • Gritsun TS, Holmes EC, Gould EA. 1995. Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis. Virus Res. 35:307–32l.
  • Gritsun TS, Lashkevich VA, Gould EA. 2003. Tick-borne encephalitis. Antiviral Res. 57:129–146.
  • Grygorczuk S, Czupryna P, Pancewicz S, Świerzbińska R, Kondrusik M, Dunaj J, Zajkowska J, Moniuszko-Malinowska A. 2018. Intrathecal expression of IL-5 and humoral response in patients with tick-borne encephalitis. Ticks Tick Borne Dis. 9:896–911.
  • Günther G, Haglund M, Lindquist L, Sköldenberg B, Forsgren M. 1997. Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome. Clin Diagn Virol. 8:17–29.
  • Hayasaka D, Gritsun TS, Yoshii K, Ueki T, Goto A, Mizutani T, Kariwa H, Iwasaki T, Gould EA, Takashima I. 2004. Amino acid changes responsible for attenuation of virus neurovirulence in an infectious cDNA clone of the Oshima strain of tick-borne encephalitis virus. J Gen Virol. 85:1007–1018.
  • Heinz FX, Kunz C. 1981. Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol. 57:263–274.
  • Hermance ME, Thangamani S. 2018. Tick-virus-host interactions at the cutaneous interface: the nidus of flavivirus transmission. Viruses 10:pii:362.
  • Holzmann H. 2003. Diagnosis of tick-borne encephalitis. Vaccine 21(Suppl 1):S36–S40.
  • Holzmann H, Heinz FX, Mandl CW, Guirakhoo F, Kunz C. 1990. A single amino acid substitution in the envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J Virol. 64:5156–5159.
  • Holzmann H, Stiasny K, Ecker M, Kunz C, Heinz FX. 1997. Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J Gen Virol. 78:31–37.
  • Hudopisk N, Korva M, Janet E, Simetinger M, Grgič-Vitek M, Gubenšek J, Natek V, Kraigher A, Strle F, Avšič-Županc T. 2013. Tick-borne encephalitis associated with consumption of raw goat milk, Slovenia, 2012. Emerg Infect Dis. 19:806–808.
  • Imhoff M, Hagedorn P, Schulze Y, Hellenbrand W, Pfeffer M, Niedrig M. 2015. Review: sentinels of tick-borne encephalitis risk. Ticks Tick Borne Dis. 6:592–600.
  • Jääskeläinen A, Tonteri E, Pieninkeroinen I, Sironen T, Voutilainen L, Kuusi M, Vaheri A, Vapalahti O. 2016. Siberian subtype tick-borne encephalitis virus in Ixodes ricinus in a newly emerged focus, Finland. Ticks Tick Borne Dis. 7:216–223.
  • Jacobs SC, Stephenson JR, Wilkinson GW. 1992. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J Virol. 66: 2086–2095.
  • Karelis G, Bormane A, Logina I, Lucenko I, Suna N, Krumina A, Donaghy M. 2012. Tick-borne encephalitis in Latvia 1973–2009: epidemiology, clinical features and sequelae. Eur J Neurol. 19:62–68.
  • Kellman EM, Offerdahl DK, Melik W, Bloom ME. 2018. Viral determinants of virulence in tick-borne flaviviruses. Viruses 10:pii:329.
  • Khasnatinov MA, Tuplin A, Gritsun DJ, Slovak M, Kazimirova M, Lickova M, Havlikova S, Klempa B, Labuda M, Gould EA, Gritsun TS. 2016. Tick-borne encephalitis virus structural proteins are the primary viral determinants of non-viraemic transmission between ticks whereas non-structural proteins affect cytotoxicity. PLoS One. 11:e0158105.
  • Khasnatinov MA, Ustanikova K, Frolova TV, Pogodina VV, Bochkova NG, Levina LS, Slovak M, Kazimirova M, Labuda M, Klempa B, et al. 2009. Non-hemagglutinating flaviviruses: molecular mechanisms for the emergence of new strains via adaptation to European ticks. PLoS One. 4:e7295.
  • Kindberg E, Mickiene A, Ax C, Akerlind B, Vene S, Lindquist L, Lundkvist A, Svensson L. 2008. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis. 197:266–269.
  • Kindberg E, Vene S, Mickiene A, Lundkvist Å, Lindquist L, Svensson L. 2011. A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection. J Infect Dis. 203:523–528.
  • Kofler RM, Hoenninger VM, Thurner C, Mandl CW. 2006. Functional analysis of the tick-borne encephalitis virus cyclization elements indicates major differences between mosquito-borne and tick-borne flaviviruses. J Virol. 80:4099–4113.
  • Kozlova IV, Demina TV, Tkachev SE, Doroshchenko EK, Lisak OV, Verkhozina MM, Karan LS, Dzhioev YP, Paramonov AI, Suntsova OV, et al. 2018. Characteristics of the Baikal subtype of tick-borne encephalitis virus circulating in Eastern Siberia. Acta Biomed Sci. 3:53–60.
  • Kozuch O, Chunikhin SP, Gresíková M, Nosek J, Kurenkov VB, Lysý J. 1981. Experimental characteristics of viraemia caused by two strains of tick-borne encephalitis virus in small rodents. Acta Virol. 25:219–224.
  • Kozuch O, Grulich I, Nosek J. 1966. Experimental infection of the mole with tick-borne encephalitis virus. J Hyg Epidemiol Microbiol Immunol. 10:120–124.
  • Kozuch O, Nosek J, Lichard M, Chmela J, Ernek E. 1967. Experimental infection of Pitymys subterraneus with tick-borne encephalitis virus. Acta Virol. 11:464–466.
  • Kroschewski H, Allison SL, Heinz FX, Mandl CW. 2003. Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. Virology 308:92–100.
  • Krylova NV, Smolina TP, Leonova GN. 2015. Molecular mechanisms of interaction between human immune cells and Far Eastern tick-borne encephalitis virus strains. Viral Immunol. 28:272–281.
  • Kuivanen S, Smura T, Rantanen K, Kämppi L, Kantonen J, Kero M, Jääskeläinen A, Jääskeläinen AJ, Sane J, Myllykangas L, et al. 2018. Fatal tick-borne encephalitis virus infections caused by Siberian and European subtypes, Finland, 2015. Emerging Infect Dis. 24:946–948.
  • Labuda M, Austyn JM, Zuffova E, Kozuch O, Fuchsberger N, Lysy J, Nuttall PA. 1996. Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology 219:357–366.
  • Labuda M, Jones LD, Williams T, Nuttall PA. 1993. Enhancement of tick-borne encephalitis virus transmission by tick salivary gland extracts. Med Vet Entomol. 7:193–196.
  • Lenhard T, Ott D, Jakob NJ, Pham M, Bäumer P, Martinez-Torres F, Meyding-Lamadé U. 2016. Predictors, neuroimaging characteristics and long-term outcome of severe European tick-borne encephalitis: a prospective cohort study. PLoS One. 11:e0154143.
  • Leonova GN, Belikov SI, Kondratov IG. 2017. Characteristics of Far Eastern strains of tick-borne encephalitis virus. Arch Virol. 162:2211–2218.
  • Leonova GN, Belikov SI, Kondratov IG, Takashima I. 2013. Comprehensive assessment of the genetics and virulence of tick-borne encephalitis virus strains isolated from patients with inapparent and clinical forms of the infection in the Russian Far East. Virology 443:89–98.
  • Leonova GN, Maystrovskaya OS, Kondratov IG, Takashima I, Belikov SI. 2014. The nature of replication of tick-borne encephalitis virus strains isolated from residents of the Russian Far East with inapparent and clinical forms of infection. Virus Res. 189:34–42.
  • Lieskovská J, Páleníková J, Langhansová H, Chmelař J, Kopecký J. 2018. Saliva of Ixodes ricinus enhances TBE virus replication in dendritic cells by modulation of pro-survival Akt pathway. Virology 514:98–105.
  • Lindenbach BD, Rice CM. 2001. Flaviviridae. The viruses and their replication. In: Knippe DM, Howley PM, editors. Fields virology. Philadelphia (PA): Lippincott Williams & Wilkins; p. 991–1042.
  • Lindquist L, Vapalahti O. 2008. Tick-borne encephalitis. Lancet 371:1861–1871.
  • Lindqvist R, Kurhade C, Gilthorpe JD, Överby AK. 2018. Cell-type- and region-specific restriction of neurotropic flavivirus infection by viperin. J Neuroinflamm. 15:80.
  • Lindqvist R, Mundt F, Gilthorpe JD, Wölfel S, Gekara NO, Kröger A, Överby AK. 2016. Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects. J Neuroinflamm. 13(1):277
  • Lipowski D, Popiel M, Perlejewski K, Nakamura S, Bukowska-Osko I, Rzadkiewicz E, Dzieciatkowski T, Milecka A, Wenski W, Ciszek M, et al. 2017. A cluster of fatal tick-borne encephalitis virus infection in organ transplant setting. J Infect Dis. 215:896–901.
  • Litov AG, Deviatkin AA, Goptar IA, Dedkov VG, Gmyl AP, Markelov ML, Shipulin GA, Karganova GG. 2018. Evaluation of the population heterogeneity of TBEV laboratory variants using high-throughput sequencing. J Gen Virol. 99:240–245.
  • Lorenz IC, Allison SL, Heinz FX, Helenius A. 2002. Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol. 76:5480–5491.
  • Lorenz IC, Kartenbeck J, Mezzacasa A, Allison SL, Heinz FX, Helenius A. 2003. Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol. 77:4370–4382.
  • Malenko GV, Fokina GI, Levina LS, Mamonenko LL, Rzhakhova OE, Pogodina VV, Frolova MP. 1982. Persistence of tick-borne encephalitis virus IV. Virus localization after intracerebral inoculation. Acta Virol. 26:362–368.
  • Malygin AA, Bondarenko EI, Ivanisenko VA, Protopopova EV, Karpova GG, Loktev VB. 2009. C-terminal fragment of human laminin-binding protein contains a receptor domain for venezuelan equine encephalitis and tick-borne encephalitis viruses. Biochemistry Mosc. 74:1328–1336.
  • Mandl CW. 2005. Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis. Virus Res. 111:161–174.
  • Mandl CW, Allison SL, Holzmann H, Meixner T, Heinz FX. 2000. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol. 74:9601–9609.
  • Mandl CW, Ecker M, Holzmann H, Kunz C, Heinz FX. 1997. Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain. Hypr J Gen Virol. 78:1049–1057.
  • Mandl CW, Holzmann H, Meixner T, Rauscher S, Stadler PF, Allison SL, Heinz FX. 1998. Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus . J Virol. 72:2132–2140.
  • Mansfield KL, Johnson N, Banyard AC, Núñez A, Baylis M, Solomon T, Fooks AR. 2016. Innate and adaptive immune responses to tick-borne flavivirus infection in sheep. Vet Microbiol. 185:20–28.
  • Maximova OA, Pletnev AG. 2018. Flaviviruses and the central nervous system: revisiting neuropathological concepts. Annu Rev Virol. 5:255–272.
  • Maximova OA, Ward JM, Asher DM, St Claire M, Finneyfrock BW, Speicher JM, Murphy BR, Pletnev AG. 2008. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates. J Virol. 82:5255–5268.
  • Mickienė A, Pakalnienė J, Nordgren J, Carlsson B, Hagbom M, Svensson L, Lindquist L. 2014. Polymorphisms in chemokine receptor 5 and Toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the Lithuanian population. PLoS One. 9:e106798
  • Monath TP, Heinz FX. 1996. Flaviviruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields’ virology. 3rd ed. Vol 1. Philadelphia: Lippincott-Raven; p. 961–1034.
  • Nagy A, Nagy O, Tarcsai K, Farkas Á, Takács M. 2018. First detection of tick-borne encephalitis virus RNA in clinical specimens of acutely ill patients in Hungary. Ticks Tick Borne Dis. 9:485–489.
  • Naslednikova IO, Ryazantseva NV, Novitskii VV, Lepekhin AV, Antoshina MA, Belokon VV, Tomson YV. 2005. Chronic tick-borne encephalitis virus antigenemia: possible pathogenesis pathways. Bull Exp Biol Med. 139:451–454.
  • Orlinger KK, Hoenninger VM, Kofler RM, Mandl CW. 2006. Construction and mutagenesis of an artificial bicistronic tick-borne encephalitis virus genome reveals an essential function of the second transmembrane region of protein E in flavivirus assembly. J Virol. 80:12197–12208.
  • Överby AK, Popov VL, Niedrig M, Weber F. 2010. Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol. 84:8470–8483.
  • Palus M, Bílý T, Elsterová J, Langhansová H, Salát J, Vancová M, Růžek D. 2014. Infection and injury of human astrocytes by tick-borne encephalitis virus. J Gen Virol. 95:2411–2426.
  • Palus M, Vancová M, Sirmarova J, Elsterova J, Perner J, Růzek D. 2017. Tick-borne encephalitis virus infects human brain microvascular endothelial cells without compromising blood-brain barrier integrity. Virology. 507:110–122.
  • Palus M, Vojtíšková J, Salát J, Kopecký J, Grubhoffer L, Lipoldová M, Demant P, Růžek D. 2013. Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system. J Neuroinflammation. 10:77.
  • Pfeffer M, Dobler G. 2011. Tick-borne encephalitis virus in dogs-is this an issue? Parasit Vectors. 4:59
  • Phillpotts RJ, Stephenson JR, Porterfield JS. 1985. Antibody-dependent enhancement of tick-borne encephalitis virus infectivity. J Gen Virol. 66:1831–1837.
  • Pletnev AG, Bray M, Huggins J, Lai CJ. 1992. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc Natl Acad Sci USA. 89:10532–10536.
  • Pletnev AG, Bray M, Lai CJ. 1993. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. J Virol. 67:4956–4963.
  • Pletnev AG, Swayne DE, Speicher J, Rumyantsev AA, Murphy BR. 2006. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine. 24(40–41):6392–404.
  • Pogodina VV, Frolova MP, Malenko GV, Fokina GI, Levina LS, Mamonenko LL, Koreshkova GV, Ralf NM. 1981a. Persistence of tick-borne encephalitis virus in monkeys. I. Features of experimental infection. Acta Virol. 6:337–343.
  • Pogodina VV, Levina LS, Fokina GI, Koreshkova GV, Malenko GV, Bochkova NG, Rzhakhova OE. 1981b. Persistence of tick-borne encephalitis virus in monkeys. III. Phenotypes of the persisting virus. Acta Virol. 6:352–360.
  • Poponnikova TV. 2006. Specific clinical and epidemiological features of tick-borne encephalitis in Western Siberia. Int J Med Microbiol. 296: 59–62.
  • Potokar M, Jorgačevski J, Zorec R. 2019. Astrocytes in flavivirus infections. IJMS 20:pii:691.
  • Potokar M, Korva M, Jorgacevski J, Avsic-Zupanc T, Zorec R. 2014. Tick-borne encephalitis virus infects rat astrocytes but does not affect their viability. PLoS One. 9:e86219.
  • Pripuzova NS, Gmyl LV, Romanova LI, Tereshkina NV, Rogova YV, Terekhina LL, Kozlovskaya LI, Vorovitch MF, Grishina KG, Timofeev AV, Karganova GG. 2013. Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy. PLoS One. 8:e61094.
  • Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 375:291–298.
  • Robertson SJ, Lubick KJ, Freedman BA, Carmody AB, Best SM. 2014. Tick-borne flaviviruses antagonize both IRF-1 and` I IFN signaling to inhibit dendritic cell function. J Immunol. 192:2744–2755.
  • Robertson SJ, Mitzel DN, Taylor RT, Best SM, Bloom ME. 2009. Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures. Immunol Res. 43:172–186.
  • Romanova LIu, Gmyl AP, Dzhivanian TI, Bakhmutov DV, Lukashev AN, Gmyl LV, Rumyantsev AA, Burenkova LA, Lashkevich VA, Karganova GG. 2007. Microevolution of tick-borne encephalitis virus in course of host alternation. Virology. 362:75–84.
  • Rumyantsev AA, Chanock RM, Murphy BR, Pletnev AG. 2006. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Vaccine. 24:133–143.
  • Rumyantsev AA, Murphy BR, Pletnev AG. 2006. A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice. J Virol. 80:1427–1439.
  • Růzek D, Dobler G, Donoso Mantke O. 2010. Tick-borne encephalitis: pathogenesis and clinical implications. Travel Med Infect Dis. 8:223–232.
  • Růzek D, Gritsun TS, Forrester NL, Gould EA, Kopecký J, Golovchenko M, Rudenko N, Grubhoffer L. 2008. Mutations in the NS2B and NS3 genes affect mouse neuroinvasiveness of a Western European field strain of tick-borne encephalitis virus. Virology. 374:249–255.
  • Růzek D, Salát J, Palus M, Gritsun TS, Gould EA, Dyková I, Skallová A, Jelínek J, Kopecký J, Grubhoffer L. 2009a. CD8+ T-cells mediate immunopathology in tick-borne encephalitis. Virology 384:1–6.
  • Růzek D, Vancová M, Tesarová M, Ahantarig A, Kopecký J, Grubhoffer L. 2009b. Morphological changes in human neural cells following tick-borne encephalitis virus infection. J Gen Virol. 90:1649–1658.
  • Sakai M, Muto M, Hirano M, Kariwa H, Yoshii K. 2015. Virulence of tick-borne encephalitis virus is associated with intact conformational viral RNA structures in the variable region of the 3'-UTR. Virus Res. 203:36–40.
  • Sakai M, Yoshii K, Sunden Y, Yokozawa K, Hirano M, Kariwa H. 2014. Variable region of the 3’UTR is a critical virulence factor in the Far-Eastern subtype of tick-borne encephalitis virus in a mouse model. J Gen Virol. 95:823–835.
  • Saksida A, Duh D, Lotric-Furlan S, Strle F, Petrovec M, Avsic-Zupanc T. 2005. The importance of tick-borne encephalitis virus RNA detection for early differential diagnosis of tick-borne encephalitis. J Clin Virol. 33:331–335.
  • Saksida A, Jakopin N, Jelovšek M, Knap N, Fajs L, Lusa L, Lotrič-Furlan S, Bogovič P, Arnež M, Strle F, Avšič-Županc T. 2018. Virus RNA load in patients with tick-borne encephalitis, Slovenia. Emerging Infect Dis. 24:1315–1323.
  • Schalich J, Allison SL, Stiasny K, Mandl CW, Kunz C, Heinz FX. 1996. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol. 70:4549–4557.
  • Schwaiger J, Aberle JH, Stiasny K, Knapp B, Schreiner W, Fae I, Fischer G, Scheinost O, Chmelik V, Heinz FX. 2014. Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction. J Virol. 88:7828–7842.
  • Senigl F, Kopecký J, Grubhoffer L. 2004. Distribution of E and NS1 proteins of TBE virus in mammalian and tick cells. Folia Microbiol (Praha). 49:213–216.
  • Shevtsova AS, Motuzova OV, Kuragina VM, Akhmatova NK, Gmyl LV, Kondrat'eva YI, Kozlovskaya LI, Rogova YV, Litov AG, Romanova LI, Karganova GG. 2017. Lethal experimental tick-borne encephalitis infection: influence of two strains with similar virulence on the immune response. Front Microbiol. 7.7:2172
  • Slonim D, Závadová A. 1977. Viremia and serum antibodies in Syrian hamster after inapparent infection with European tick-borne encephalitis virus. J Hyg Epidemiol Microbiol Immunol. 21:169–173.
  • Šmit R, Postma MJ. 2015. The burden of tick-borne encephalitis in disability-adjusted life years (DALYs) for Slovenia. PLoS One. 10:e0144988.
  • Stadler K, Allison SL, Schalich J, Heinz FX. 1997. Proteolytic activation of tick-borne encephalitis virus by furin. J Virol. 71:8475–8481.
  • Süss J, Dobler G, Zöller G, Essbauer S, Pfeffer M, Klaus C, Liebler-Tenorio EM, Gelpi E, Stark B, Hotzel H. 2008. Genetic characterization of a tick-borne encephalitis virus isolated from the brain of a naturally exposed monkey (Macaca sylvanus). Int J Med Microbiol. 298:295–300.
  • Süss J, Gelpi E, Klaus C, Bagon A, Liebler-Tenorio EM, Budka H, Stark B, Müller W, Hotzel H. 2007. Tick-borne encephalitis in a natur ally exposed monkey (Macaca sylvanus). Emerg Infect Dis. 13:905–907.
  • Süss J. 2008b. Tick-borne encephalitis in Europe and beyond—the epidemiological situation as of 2007. Eur Surveill. 13:2–9.
  • Taba P, Schmutzhard E, Forsberg P, Lutsar I, Ljostad U, Mygland A, Levchenko I, Strle F, Steiner I. 2017. EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis. Eur J Neurol. 24:1214–1e61.
  • Takano A, Yoshii K, Omori-Urabe Y, Yokozawa K, Kariwa H, Takashima I. 2011. Construction of a replicon and an infectious cDNA clone of the Sofjin strain of the Far-Eastern subtype of tick-borne encephalitis virus. Arch Virol. 156:1931–1941.
  • Tomazic J, Ihan A. 1997. Flow cytometric analysis of lymphocytes in cerebrospinal fluid in patients with tick-borne encephalitis. Acta Neurol Scand. 95:29–33.
  • Tomazic J, Poljak M, Popovic P, Maticic M, Beovic B, Avsic-Zupanc T, Lotric S, Jereb M, Pikelj F, Gale N. 1997. Tick-borne encephalitis: possibly a fatal disease in its acute stage. PCR amplification of TBE RNA from postmortem brain tissue. Infection. 25:41–43.
  • Veje M, Studahl M, Johansson M, Johansson P, Nolskog P, Bergstrom T. 2018. Diagnosing tick-borne encephalitis: a re-evaluation of notified cases. Eur J Clin Microbiol Infect Dis. 37:339–344.
  • Votiakov I, Protas II, Bortkevich S, Nedz’ved MK. 1975. Experimental study of the pathogenesis of tick-borne encephalitis. Vopr Virusol. 3:313–317.
  • Votiakov I, Protas II, Zhdanov VM. 1982. Western tick-borne encephalitis in Eurasia. Belarus, Minsk, 256 pp. Vopr Virusol. 1:103–106.
  • Wallner G, Mandl CW, Ecker M, Holzmann H, Stiasny K, Kunz C, Heinz FX. 1996. Characterization and complete genome sequences of high- and low- virulence variants of tick-borne encephalitis virus. J Gen Virol. 77:1035–1042.
  • Weisheit S, Villar M, Tykalová H, Popara M, Loecherbach J, Watson M, Růžek D, Grubhoffer L, de la Fuente J, Fazakerley JK, Bell-Sakyi L. 2015. Ixodes scapularis and Ixodes ricinus tick cell lines respond to infection with tick-borne encephalitis virus: transcriptomic and proteomic analysis. Parasit Vectors. 8:599.
  • Wengler G, Wengler G. 1989. Cell-associated West Nile flavivirus is covered with E + Pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol. 63:2521–2526.
  • Wengler G, Wengler G. 1991. The carboxy-terminal part of the NS3 protein of the West Nile virus flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA stimulated NTPase. Virology. 184:707–715.
  • Winkler G, Randolph VB, Cleaves GR, Ryan TE, Stollar V. 1988. Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology 162:187–196.
  • Yoshii K, Hayasaka D, Goto A, Obara M, Araki K, Yoshimatsu K, Arikawa J, Ivanov L, Mizutani T, Kariwa H, Takashima I. 2003. Enzyme-linked immunosorbent assay using recombinant antigens expressed in mammalian cells for serodiagnosis of tickborne encephalitis. J Virol Methods. 108:171–179.
  • Yoshii K, Song JY, Park SB, Yang J, Schmitt HJ. 2017. Tick-borne encephalitis in Japan, Republic of Korea and China. Emerg Microbes Infect. 6:e82.
  • Zambito Marsala S, Pistacchi M, Gioulis M, Mel R, Marchini C, Francavilla E. 2014. Neurological complications of tick borne encephalitis: the experience of 89 patients studied and literature review. Neurol Sci. 35:15–21.
  • Zlontnik I, Grant DP, Carter GB. 1976. Experimental infection of monkeys with viruses of the tick-borne encephalitis complex: degenerative cerebellar lesions following inapparent forms of the disease or recovery from clinical encephalitis. Br J Exp Pathol. 57:200–210.
  • Zorec R, Županc TA, Verkhratsky A. 2019. Astrogliopathology in the infectious insults of the brain. Neurosci Lett. 689:56–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.